Helping two global pharma companies uncover a winning position for launch of a new drug
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Two global pharma companies joined forces to launch a new prescription medicine for treatment of a mental health condition. The clients understood how competitive the landscape is for mental health treatment products and needed Escalent’s help to identify market needs for four audiences: patients, caregivers, psychiatrists and primary care doctors. They also needed help developing, assessing and finalizing the strongest position for this new treatment.
Escalent facilitated in-person workshops with multidisciplinary client teams from both companies. We then conducted several rounds of qualitative research in and outside the US. We used pre-research activities—patient chart pulls for doctors and photo stories for patients—as well as storytelling to gain a comprehensive understanding of the impact of mental conditions. Then we overlaid the unmet needs of the market with the new treatment’s benefits and tested four market insights. By blending this qualitative research with the clients’ previous quantitative research, we identified one very strong insight that was used to develop and test the elements of the product positioning story.
We successfully identified one specific need and crafted a meaningful and durable positioning recommendation to senior management. The clients were extremely pleased with how well the positioning was constructed—it was believable, important and achievable. The clients launched the product using our recommendation as the backbone of the positioning and continue to use the positioning two years later. Global sales are approaching half a billion dollars and the clients’ brand strength has improved year over year.
As asset managers increasingly focus on promoting a unified corporate brand, new data from Cogent Syndicated reveal an opportunity for messaging to help firms define their unique value proposition in the current US advisor market.
While the term “Brand Authenticity” buzzes across industries, organizations need to know who they truly are to live up to that ideal to build brand trust and attract loyal customers. Escalent's Rob Darrow shares three brand authenticity lessons to help you bridge the gap between your brand's ideal and actual state.
As financial institutions race to get positioned to capture their share of one of the largest, most historical transfers of wealth, they must understand how they can differentiate themselves to secure a competitive advantage.
In pharma today, trust is incredibly hard to gain and alarmingly quick to lose. Manufacturers recognize the power of telling a more complete brand story to build stronger customer relationships but must go further to build the most relevant and trusted brand. Find out how.
Escalent’s technology experts explore how understanding the origins of generative artificial intelligence (AI) can help tech companies effectively strategize on integrating generative AI into their business and offerings for maximum customer impact
Uncertainty shocks are here to stay. Brace for change with market intelligence, Implementation Consultants and foresight.
As asset managers increasingly focus on promoting a unified corporate brand, new data from Cogent Syndicated reveal an opportunity for messaging to help firms define their unique value proposition in the current US advisor market.
Join our investor experts, Steve Ethridge and Kristin Hall as they share insights and a first look at our new Cogent Syndicated report Trajectory of Intergenerational Wealth Transfer™ .
As more alternative investment products become available to affluent investors, our latest Cogent Syndicated report reveals the need for appropriate advisor and client education by asset managers in the space.
